Literature DB >> 1625783

Abnormal electroretinography in schizophrenic patients with a history of sun gazing.

H Gerbaldo1, G Thaker, P G Tittel, J Layne-Gedge, M Moran, L Demisch.   

Abstract

Electroretinographic (ERG) measurements were performed in 9 schizophrenic patients and in 13 control subjects. The measurements of schizophrenic patients as a group did not differ from those of normals. However, 6 schizophrenic patients who had a past history of sun gazing showed a decrease in retinal responsiveness under conditions of light adaptation. These results suggest that a subgroup of schizophrenic patients, who show deviant light-related behavior, have abnormal ERG. We postulate that an abnormality in retinal dopaminergic neurons, which are known to reduce light responsiveness of horizontal and ganglion cells, is the underlying pathophysiology of this clinical finding.

Entities:  

Mesh:

Year:  1992        PMID: 1625783     DOI: 10.1159/000118816

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  4 in total

1.  Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia.

Authors:  Walter L Slaghuis
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

2.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

Review 3.  THE USE OF ELECTRORETINOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH SCHIZOPHRENIA.

Authors:  Din Duraković; Ante Silić; Vjekoslav Peitl; Rašeljka Tadić; Kristina Lončarić; Trpimir Glavina; Daniela Šago; Ljiljana Pačić Turk; Dalibor Karlović
Journal:  Acta Clin Croat       Date:  2020-12       Impact factor: 0.932

4.  Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis.

Authors:  Nathalia Torres Jimenez; Justin W Lines; Rachel B Kueppers; Paulo Kofuji; Henry Wei; Amy Rankila; Joseph T Coyle; Robert F Miller; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.